Clariant is set to expand its Care Chemicals facility in Daya Bay, Huizhou, China through an investment equivalent to U.S. $86.7 million to boost its support for pharmaceutical, personal care, home care and industrial application customers.
By obtaining the drug GMP certificate, the Clariant Daya Bay manufacturing site has become an API manufacturer in China with certified polyethylene glycol (Polyglykol 3350) and plans to introduce new products by the end of 2024.
The site will become a global hub for Clariant’s health care business support. Clariant will also expand existing production capacity for its Ethylene Oxide Derivatives (EODs) and offer a broader chemical portfolio at Daya Bay. This will allow the company to produce more sustainable ingredients and help customers meet their environmental targets.
Hostapon (INCI: Sodium Cocoyl Glycinate) is an example of one of these ingredients. It is a mild surfactant for personal care brands and formulators in developing milder, cleaner beauty in applications such as solid beauty bars, body washes and cream-type shampoos.
Christian Vang, head of Clariant Care Chemicals, commented: “The many market segments we serve from Daya Bay are evolving to reflect changing sustainability targets and end-product performance needs, and we want to bring our own innovation and expertise closer to these customers to help drive their developments forward."